Australian Clinical Labs Ltd ( (AU:ACL) ) has shared an announcement.
Australian Clinical Labs Ltd has announced an update on its ongoing share buy-back program, with a total of 3,678,500 ordinary fully paid securities bought back before the previous day and an additional 150,000 securities acquired on the previous day. This buy-back initiative is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value.
More about Australian Clinical Labs Ltd
Australian Clinical Labs Ltd operates in the healthcare industry, focusing on providing pathology services. The company is known for its diagnostic testing services, catering to various medical needs across Australia.
YTD Price Performance: -10.88%
Average Trading Volume: 985,163
Technical Sentiment Signal: Buy
Current Market Cap: A$601.7M
Learn more about ACL stock on TipRanks’ Stock Analysis page.